Metabolic Syndrome, But Not NAFLD, Increases 10-year Mortality Metabolic Syndrome, But Not NAFLD, Increases 10-year Mortality
This study compared 10-year mortality among those with and without NAFLD in an urban South Asia cohort. What factors were associated with early risk of death?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 11, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Many Patients With NAFLD Should Be Screened for Liver Cancer, Experts Say Many Patients With NAFLD Should Be Screened for Liver Cancer, Experts Say
Screening and surveillance for hepatocellular carcinoma (HCC) is important in many patients with nonalcoholic fatty liver disease (NAFLD), according to an expert panel of the American Gastroenterological Association (AGA).Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 11, 2020 Category: Pathology Tags: Gastroenterology News Source Type: news

Modifiable Risk Factors and Long-term Outcomes of NAFLD Modifiable Risk Factors and Long-term Outcomes of NAFLD
Cardiovascular disease is a leading cause of mortality in patients with non-alcoholic fatty liver disease. Can modifying CV risk factors and health behaviors improve outcomes?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 5, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FibrometerV2G vs. Enhanced Liver Fibrosis Score in NAFLD FibrometerV2G vs. Enhanced Liver Fibrosis Score in NAFLD
Do the Enhanced Liver Fibrosis score and the FibroMeterV2G have equal accuracy in the non-invasive diagnosis of advanced liver fibrosis in patients with NAFLD?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 6, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

NAFLD in Nonobese Subjects of African Origin NAFLD in Nonobese Subjects of African Origin
How do the metabolic features of nonobese NAFLD among persons of African origin differ from those in other populations?Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 19, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Researchers look at the ability of cordyceps to "burn" fat in the liver
(Natural News) Extracts from the medicinal mushroom Cordyceps militaris can potentially be used to prevent — even reverse — nonalcoholic fatty liver disease (NAFLD), one of the most prevalent forms of liver disease among American adults. In a study published in the Journal of Medicinal Food, researchers from South Korea investigated whether C. militaris can regulate lipogenesis in the... (Source: NaturalNews.com)
Source: NaturalNews.com - December 12, 2019 Category: Consumer Health News Source Type: news

Taming chronic inflammation may reduce illness, save lives
Scientists from 22 institutions, including UCLA, are recommending early diagnosis, prevention and treatment of severe chronic inflammation to reduce the risk of chronic disease and death worldwide.The group of international experts, which also includes scientists from the National Institutes of Health, Stanford University, Harvard Medical School, Columbia University Medical Center and University College London, point to inflammation-related diseases as the cause of 50 percent of all deaths worldwide.Inflammation is a naturally occurring response by the body ’s immune system that helps fight illness and infection. Whe...
Source: UCLA Newsroom: Health Sciences - December 5, 2019 Category: Universities & Medical Training Source Type: news

Zydus Cadila files NDA for Saroglitazar Magnesium
NASH is a progressive disease of the liver and a significant unmet medical need. There are currently no treatments available for the treatment of NASH. aroglitazar Mg has previously demonstrated improvement in both liver enzymes along with favorable effects on lipid and glycemic indices in patients with nonalcoholic fatty liver disease in Phase II clinical trials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2019 Category: Pharmaceuticals Source Type: news

Tesamorelin Resolves NAFLD in Some HIV Patients Tesamorelin Resolves NAFLD in Some HIV Patients
Tesamorelin can reduce liver fat and prevent fibrosis progression in HIV patients with non-alcoholic fatty liver disease (NAFLD), according to a new phase-2 trial.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 16, 2019 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Characteristics, Trends of HCC in Patients Without Cirrhosis Characteristics, Trends of HCC in Patients Without Cirrhosis
This study aimed to describe the frequency and characteristics of non-cirrhotic hepatocellular carcinoma. What contribution does NAFLD make to the burden of non-cirrhotic HCC?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 30, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Green cardamom supplements can protect the liver for those with obesity
(Natural News) Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease today. Fatty liver is commonly caused by excessive alcohol intake. However, as its name implies, NAFLD can develop with little to no alcohol consumption. New research published in the journal BMC Complementary and Alternative Medicine suggested that people with NAFLD may benefit... (Source: NaturalNews.com)
Source: NaturalNews.com - October 29, 2019 Category: Consumer Health News Source Type: news

Researchers identify protein that can protect against non-alcoholic fatty liver disease
(Natural News) Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases in developed countries. Statistics show that about 25 percent of the world’s population suffer from this disease. As its name implies, NAFLD is not caused by excessive alcohol consumption; it is characterized by too much fat stored in liver cells. Patients with... (Source: NaturalNews.com)
Source: NaturalNews.com - October 28, 2019 Category: Consumer Health News Source Type: news

NAFLD Not Associated With Risk of Cardiovascular Disease NAFLD Not Associated With Risk of Cardiovascular Disease
Non-alcoholic fatty liver disease (NAFLD) is not associated with an increased risk of acute myocardial infarction (AMI) or stroke, according to a new cohort study in nearly 18 million Europeans.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Association Between Nut Consumption and NAFLD in Adults Association Between Nut Consumption and NAFLD in Adults
Might nut consumption be protective against development of non-alcoholic fatty liver disease?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Clinical Prediction Score of NAFLD in Adolescents With PCOS Clinical Prediction Score of NAFLD in Adolescents With PCOS
Learn more about a newly developed clinical score to identify the potential risk for NAFLD in patients with PCOS.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Tesamorelin May Aid Patients With HIV, Fatty Liver Disease
WEDNESDAY, Oct. 16, 2019 -- Tesamorelin reduces liver fat content in patients with HIV and nonalcoholic fatty liver disease (NAFLD), according to a study published online Oct. 11 in The Lancet HIV. Takara L. Stanley, M.D., from Massachusetts General... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2019 Category: Pharmaceuticals Source Type: news

Metabolically Healthy Obesity and Fibrosis Progression in NAFLD Metabolically Healthy Obesity and Fibrosis Progression in NAFLD
Do obese individuals with NAFLD who are"metabolically healthy" (i.e., without diabetes, hypertension or high lipid levels) differ in fibrosis progression versus those with these risk factors?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 16, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Probiotics and Prebiotics as Treatment for NAFLD Probiotics and Prebiotics as Treatment for NAFLD
This article explores different microbiota modulation strategies for the treatment of NAFLD-NASH.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 16, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Depression Is Associated With NAFLD Among US Adults Depression Is Associated With NAFLD Among US Adults
Might depression be a modifiable risk factor for NAFLD?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 14, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

NAFLD, Liver Fibrosis Score and Cognitive Function in Adults NAFLD, Liver Fibrosis Score and Cognitive Function in Adults
Is there an association between liver fibrosis, even prior to its clinical manifestation, and impairment in cognitive function in older adults?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

New drug improves abnormalities associated with metabolic syndrome
A newly developed drug for treating metabolic syndrome safely reduces plasma triglycerides and LDL cholesterol, and reverses NAFLD and liver insulin resistance, according to a study published inScience Translational Medicine.MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 4, 2019 Category: Endocrinology Source Type: news

New drug helps combat metabolic syndrome
In nonhuman trials, the drug has been shown to safely reduce plasma triglycerides and “bad” LDL cholesterol, and to reverse nonalcoholic fatty liver disease. (Source: Yale Science and Health News)
Source: Yale Science and Health News - October 2, 2019 Category: Universities & Medical Training Source Type: news

NASH and Risk of Advanced Colorectal Neoplasm NASH and Risk of Advanced Colorectal Neoplasm
This study indicates that the histological severity of NAFLD is strongly associated with advanced colorectal neoplasm.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 2, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Can AI screen for nonalcoholic fatty liver disease?
An artificial intelligence (AI) algorithm was able to automatically quantify...Read more on AuntMinnie.comRelated Reading: Ultrasound useful for evaluating liver steatosis MRI offers view of liver fat loss in obese patients Ultrasound options abound for diagnosing liver disease AIUM: Can deep learning classify liver fibrosis on US? Fatty liver disease occurs with risky plaque (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 20, 2019 Category: Radiology Source Type: news

Gut Microbe Linked to Nonalcoholic Fatty Liver Disease
Researchers find strains of the bacterium Klebsiella pneumoniae that produce high levels of alcohol in 60 percent of patients with the condition. (Source: The Scientist)
Source: The Scientist - September 19, 2019 Category: Science Tags: News & Opinion Source Type: news

Medical News Today: Gut bacteria may damage liver by turning carbs into alcohol
Researchers find strains of gut bacteria that turn carbohydrates into alcohol. This may contribute to nonalcoholic fatty liver disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 19, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

Former Brexit MP DAVID DAVIS reveals the low-carb diet that helped transform his health 
DAVID DAVIS:A year ago, after I resigned from my Cabinet job as Brexit Secretary, I had a routine medical. The doctor frowned, I had non-alcoholic fatty liver disease (NAFLD). (Source: the Mail online | Health)
Source: the Mail online | Health - September 17, 2019 Category: Consumer Health News Source Type: news

Mixed Outcomes After Liver Resection for NAFLD-Associated Cancer Mixed Outcomes After Liver Resection for NAFLD-Associated Cancer
Liver resection for nonalcoholic fatty liver disease (NAFLD)-associated hepatocellular carcinoma (HCC) is associated with favorable long-term survival but with more surgical morbidity and post-hepatectomy liver failure, compared with non-NAFLD HCC, researchers from Singapore report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 28, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Role of the Gut Microbiome in the Progression of NAFLD Role of the Gut Microbiome in the Progression of NAFLD
This study investigated the mechanisms by which altered gut microbiota impact the development and progression of NAFLD. Might microbiota-targeting therapies be beneficial?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 26, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Curcumin improves symptoms of NAFLD and obesity
(Natural News) Consuming large amounts of curcumin — the bioactive compound present in the spice turmeric — may help improve obesity and non-alcoholic fatty liver disease (NAFLD) in patients with both. An Iranian study found that taking curcumin supplements decreases factors that contribute to the two health conditions. The researchers compared the effects of a curcumin... (Source: NaturalNews.com)
Source: NaturalNews.com - August 13, 2019 Category: Consumer Health News Source Type: news

Prescription of Statins in Suspected NAFLD and High CVD Risk Prescription of Statins in Suspected NAFLD and High CVD Risk
Might most patients with suspected non-alcoholic fatty liver disease benefit from statin therapy?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 6, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Potential new treatment for non-alcoholic fatty liver disease
Clinical trials in Germany and Austria for a new NAFLD treatment have shown success, according to a report inThe Lancet Gastroenterology& Hepatology.Medical News Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 1, 2019 Category: Endocrinology Source Type: news

Your liver loves schisandra extract: Research shows these berries reduce risk of NAFLD, liver dysfunction
(Natural News) The berries of Schisandra sphenanthera displayed protective effects on the liver. Chinese researchers showed that an extract made from the dried fruit could delay the progression of non-alcoholic fatty liver disease. A cousin to the five-flavor fruit (Schisandra chinensis) favored by natural health practitioners, S. sphenanthera is also extensively used in China. Its fruits undergo drying and extraction processes to... (Source: NaturalNews.com)
Source: NaturalNews.com - July 30, 2019 Category: Consumer Health News Source Type: news

Medical News Today: Nonalcoholic fatty liver disease: New drug proves 'safe' and effective
A double-blind, placebo-controlled randomized clinical trial finds the right dosage at which a drug 'safely' treats nonalcoholic fatty liver disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 30, 2019 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

The Hidden Risk of Liver Disease From Diabetes
If you have type 2 diabetes, a growing body of research suggests that it's important to monitor your liver for a condition called nonalcoholic fatty liver disease (NAFLD). (Source: WebMD Health)
Source: WebMD Health - July 15, 2019 Category: Consumer Health News Source Type: news

HCC in Patients With NAFLD Without Cirrhosis HCC in Patients With NAFLD Without Cirrhosis
This study compared the clinical characteristics of patients with non-cirrhotic NAFLD-HCC to those with cirrhosis. Do outcomes differ between the two groups?Liver International (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 12, 2019 Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news

Society congratulates our new Early Career Grant awardees
Congratulations to our early career members awardedEarly Career Grants of up to£10,000 to help fund their endocrine research.Patricio Atanes(King’s College London) - Identifying obesity-induced targets in the human liver GPCR expressome: therapeutic implications fortype 2 diabetes and non-alcoholic fatty liver diseaseIoannis Christakis (University of Nottingham) - Evaluating a potential adrenal-gut axis as a therapy for Sub-Clinical Cushing’s SyndromeShelley Harris (OCDEM) - Dissecting the role of role of 5β-reductase in pancreatic islet cell morphology and hormone secretionInmaculada...
Source: Society for Endocrinology - July 3, 2019 Category: Endocrinology Source Type: news

' Liquid Biopsy' for Pediatric Fatty Liver Disease on the Horizon'Liquid Biopsy' for Pediatric Fatty Liver Disease on the Horizon
A blood test could replace the need for liver biopsy in the management of non-alcoholic fatty liver disease (NAFLD) in children within five years, European researchers predict.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - June 12, 2019 Category: Pathology Tags: Gastroenterology News Source Type: news

New blood test on horizon for the 1 in 10 children who suffer common liver disease
(Spink Health) A new blood test could become clinical practice within five years, reducing the need for a liver biopsy in the management of pediatric non-alcoholic fatty liver disease (NAFLD), as a major new international pediatric liver registry collaboration yields early results. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 7, 2019 Category: International Medicine & Public Health Source Type: news

Itchy Palms During Pregnancy? It Might Suggest Liver Disease Itchy Palms During Pregnancy? It Might Suggest Liver Disease
New research suggests a connection between nonalcoholic fatty liver disease and a rare pregnancy complication.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 30, 2019 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news

Which of these two can cause chronic liver disease? Astonishingly, they BOTH could
An estimated 20 per cent of the UK population has been diagnosed with non-alcoholic fatty liver disease (NAFLD) — up from 15 per cent in 2005. Here, two patients tell their stories. (Source: the Mail online | Health)
Source: the Mail online | Health - May 28, 2019 Category: Consumer Health News Source Type: news

T2DM Is Risk Factor for Liver Fibrosis Progression in NAFLD
FRIDAY, May 24, 2019 -- Type 2 diabetes mellitus (T2DM) is a risk factor for progression of liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD), according to a study published online May 21 in the Journal of Gastroenterology and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 24, 2019 Category: Pharmaceuticals Source Type: news

Adverse Liver Outcomes Up With Diagnosis of NAFLD/NASH
Baseline diagnosis of diabetes independent predictor of advanced liver disease diagnosis (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 22, 2019 Category: Cancer & Oncology Tags: Endocrinology, Gastroenterology, Internal Medicine, Oncology, Journal, Source Type: news

Adverse Liver Outcomes Up With Diagnosis of NAFLD/NASH
WEDNESDAY, May 22, 2019 -- The risks for cirrhosis and hepatocellular carcinoma (HCC) are increased for patients with a recorded diagnosis of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 22, 2019 Category: Pharmaceuticals Source Type: news

Daily Aspirin May Lower Risk for Fatty Liver Progression Daily Aspirin May Lower Risk for Fatty Liver Progression
Daily aspirin may reduce the risk for progression to fibrosis and NASH in fatty liver disease, observational data suggest; more research is needed before recommending daily aspirin in NAFLD.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 18, 2019 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

It's in the weeds: Herbicide linked to human liver disease
(University of California - San Diego) Exposure to glyphosate, the primary ingredient in the popular weed killer Roundup, correlates to more severe cases of nonalcoholic fatty liver disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2019 Category: International Medicine & Public Health Source Type: news

New connection found between NAFLD and rare pregnancy complication
(Digestive Disease Week) A new link has been found between a rare and serious condition that typically presents as itchy palms during pregnancy and the world's most common chronic liver disease, according to research presented at Digestive Disease Week ® (DDW) 2019. Researchers found that intrahepatic cholestasis of pregnancy (ICP), a bile acid disorder in adults that affects roughly one of every 300 pregnancies, may be associated with non-alcoholic fatty liver disease (NAFLD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news

Parental NAFLD Increases Risk of NAFLD in Offspring Parental NAFLD Increases Risk of NAFLD in Offspring
Are individuals with a parental history of hepatic steatosis at increased risk for NAFLD?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 6, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Researchers identify a protein that protects against non-alcoholic fatty liver disease
(Institute for Research in Biomedicine (IRB Barcelona)) Work headed by scientist Antonio Zorzano proposes a possible therapeutic target to treat fatty liver, a disease for which there is currently no treatment. The study, which was done in collaboration with the Pere Virgili Institute, has been published in the journal Cell. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 3, 2019 Category: Biology Source Type: news

Upcoming Xtalks Webinar: " Think Enrolling Your NASH Trial Will Be...
Not only is nonalcoholic steatohepatitis (NASH) and its precursor, nonalcoholic fatty liver disease (NAFLD), virtually unheard of among the most high-risk patient population, it’s difficult to...(PRWeb May 02, 2019)Read the full story at https://www.prweb.com/releases/upcoming_xtalks_webinar_think_enrolling_your_nash_trial_will_be_easy_think_again/prweb16283459.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 2, 2019 Category: Pharmaceuticals Source Type: news